Atlas Trials

Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)

Clinical trial NCT07393438 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07393438
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multidrug-Resistant TuberculosisRifampicin-resistant TuberculosisMDR-TBRR-TB
Start date
2026-02-21
Primary completion
2027-02-28
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.